Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
about
The Essentiality of Arachidonic Acid in Infant DevelopmentInflammatory mechanisms linking periodontal diseases to cardiovascular diseasesPeriodontal disease immunology: 'double indemnity' in protecting the hostThe pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cellsResolution of acute inflammation in the lungPro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in InflammationRedox and Src family kinase signaling control leukocyte wound attraction and neutrophil reverse migration.Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness.Serum level changes of long chain-polyunsaturated fatty acids in patients undergoing periodontal therapy combined with one year of omega-3 supplementation: a pilot randomized clinical trialEssential fatty acids in the treatment of dry eye syndrome: A myth or reality?Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway.Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1.Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.Molecular targets of omega 3 and conjugated linoleic Fatty acids - "micromanaging" cellular response.Omega-3 Fatty Acid Ethyl Esters do not Improve Clopidogrel Associated P2Y12 Inhibition in Stroke PatientsHealth implications of high dietary omega-6 polyunsaturated Fatty acids.LXA4 actions direct fibroblast function and wound closureTrends in the use of complementary health approaches among adults: United States, 2002-2012Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders.Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.Pathway Markers for Pro-resolving Lipid Mediators in Maternal and Umbilical Cord Blood: A Secondary Analysis of the Mothers, Omega-3, and Mental Health Study.Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells.MAG-DPA curbs inflammatory biomarkers and pharmacological reactivity in cytokine-triggered hyperresponsive airway models.Resolvin D1 drives establishment of Leishmania amazonensis infection.Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury.A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies.Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.Molecular biology of atherosclerosis.A cluster of immunoresolvents links coagulation to innate host defense in human blood.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.Eating the Dead to Keep Atherosclerosis at Bay.Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury.Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.XOR inhibition with febuxostat accelerates pulmonary endothelial barrier recovery and improves survival in lipopolysaccharide-induced murine sepsis.Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis.Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element.
P2860
Q26748375-45036CBA-E03F-4352-A75A-8C5CC527744DQ26997381-758B1D23-3FFA-4371-9E44-4844066025D9Q27025438-D5FABC7A-7882-48DB-95E3-A00B325E9EE4Q28397861-7A0DC2A8-7DEA-4C6E-B375-170DC4F81956Q28652204-C530334D-A883-4AED-91A9-DA31AEBF05FEQ28716294-3E3F7308-C6B0-4745-8AA8-CCB4C7A4E8B5Q30605978-B3B6D280-5DEE-4306-BC95-2723F0DA23B9Q33614869-4AD23DE8-83CA-4880-8681-77B3E63B7718Q34106302-0E58353C-8978-455B-9B1A-8923837BEBB2Q34273267-8F6C7BED-0481-4552-BBFC-BC51E90B41EFQ34407602-6C8CE6A7-4BF9-4E67-B675-21E5D34CCEA5Q34519343-E9F3B956-5A58-40CF-B729-2F92BE71F6DCQ35660086-45A98615-A079-449A-8598-E0D83D9778FCQ35789183-7613053E-F94E-4D31-ADC3-7B201D8013F5Q35868946-8F3EF952-9F90-441C-B368-CC9EB8DC88D4Q35909254-610F6DBD-3B96-4123-B431-E3C60CBDE44EQ36021645-0BF43C2E-75A6-4856-84CC-698274CAF9C5Q36069610-B7516533-7884-44D6-9855-0FFC52AA1900Q36269787-571B748D-96E5-47D8-8433-9FE47AAC8F67Q36432334-C382CA00-9B3E-499F-BC45-738338781050Q36613855-914947EB-B1E4-4EF3-A477-A8869E7532BAQ36974431-4CCE3DFD-2676-4ABA-8A42-6619C6D5D274Q37236175-3B4B1CEE-B352-4B8A-9A14-1804A0225F0BQ37409822-B3F4AAFC-A97E-4B6A-A3CD-542EFE3ED295Q37579950-7B4386A2-E619-4F0C-A3A8-2B1338800C94Q37743273-EA9F2778-ED41-49A0-8330-8BF9006A31C9Q38009737-EA268E0F-8375-477E-A308-A9457A8D161AQ38076251-F96484F4-0481-4E11-84CE-A6D78B27DD46Q38099615-1DA7B083-AEAF-4BE5-9C99-DC8F91787420Q38103051-654F3662-D84F-4D85-A4F8-DFF5F4CA254CQ38125279-4C6DBD53-D638-441F-86C6-7BBCC8EF0622Q38647952-6C61B744-86AC-4F02-8396-A9AFAC823814Q38681468-E08BBE4D-6714-4046-A7EF-BB2B816E395BQ39134393-98876D15-21B0-40D5-BBC2-446A67ED44C7Q39388843-470C9364-4DC9-4F65-B36E-8D5EE90EB67FQ39474261-3419AC74-154E-4782-A87E-DE6F19FEEF6EQ39504951-37B41EBC-481C-4185-9A12-3AE95563F1FAQ41386068-2EEF6191-480C-4F28-BC9F-8C17A7A2461FQ42197506-6E62B7D7-8F1D-4B8D-B83B-AE87914D7255Q44366212-FCED2AFF-B7B9-4D73-8FA4-AA210F919BB7
P2860
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Specialized proresolving media ...... and mechanisms of resolution.
@ast
Specialized proresolving media ...... and mechanisms of resolution.
@en
type
label
Specialized proresolving media ...... and mechanisms of resolution.
@ast
Specialized proresolving media ...... and mechanisms of resolution.
@en
prefLabel
Specialized proresolving media ...... and mechanisms of resolution.
@ast
Specialized proresolving media ...... and mechanisms of resolution.
@en
P2860
P356
P1433
P1476
Specialized proresolving media ...... and mechanisms of resolution.
@en
P2093
Charles N Serhan
Gabrielle Fredman
P2860
P304
P356
10.1042/BJ20110327
P407
P577
2011-07-01T00:00:00Z